James E. Flynn, 10% Owner: ARS Pharmaceuticals SPRY Sell · Filed 25/07/01

Trade details

Type: Insider sale
Amount: $6,831,584.5
Shares · price: 370,075 sh · $18.46 a share
Held after: 4,887,254 sh
Stock: ARS Pharmaceuticals SPRY
Person: James E. Flynn10% Owner
Trade date: 25/06/27
Filed: 25/07/01
Days to filing: 4 days

Sold 7.0% of holdings

Share of holding sold: 7.0%

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/05/28~25/07/27

James E. Flynn's recent trades

James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$10M
2,000,000 sh
$10M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$5.4M
1,084,012 sh
$5.4M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$5.4M
1,084,010 sh
$5.4M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$4.2M
831,978 sh
$4.2M
Filed 03/02
Traded 02/27
James E. FlynnDirector
SellNuvalent
Sell
Nuvalent
NUVL
$35.4M
371,287 sh
$35.4M
Filed 25/11/24
Traded 25/11/24

James E. Flynn, 10% Owner — sold $6.8M of ARS Pharmaceuticals SPRY · 7.0% of holdings | Whalegun